SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BlackRock files Schedule 13G/A for Allogene Therapeutics

A Schedule 13G/A for Allogene Therapeutics was filed by BlackRock, Inc.

ALLO

Related stories